NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma
- 1 July 2006
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 45 (1), 81-89
- https://doi.org/10.1016/j.jhep.2005.12.017
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Role of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human CancersCancer Research, 2005
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- RAS and RHO GTPases in G1-phase cell-cycle regulationNature Reviews Molecular Cell Biology, 2004
- The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complexNature, 2004
- The dark side of Ras: regulation of apoptosisOncogene, 2003
- Hepatocellular carcinomaThe Lancet, 2003
- The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 AccumulationMolecular and Cellular Biology, 2002
- Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype SuppressionJNCI Journal of the National Cancer Institute, 2001
- Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3Nature Genetics, 2000
- Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?Nature Medicine, 1996